ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

NCI Advisory Group, Other Cancer Meetings

August 30, 1991

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

Community Cancer Control Program Survives Schmidt Criticism; NCAB Votes To Continue

October 17, 1975